Saniona AB - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Saniona AB - Product Pipeline Review - 2016

Saniona AB - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Saniona AB - Product Pipeline Review - 2016
Published Aug 17, 2016
55 pages — Published Aug 17, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Saniona AB - Product Pipeline Review - 2016, provides an overview of the Saniona ABs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Saniona AB, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Saniona AB
- The report provides overview of Saniona AB including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Saniona ABs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Saniona ABs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Saniona ABs strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Saniona AB
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Saniona ABs pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08121CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Saniona AB Snapshot61
  Saniona AB Overview61
  Key Information61
  Key Facts61
Saniona AB Research and Development Overview73
  Key Therapeutic Areas73
Saniona AB Pipeline Review105
  Pipeline Products by Stage of Development101
  Pipeline Products Monotherapy111
  Pipeline Products Combination Treatment Modalities121
  Pipeline Products Out-Licensed Products131
    Out-Licensed Products/Combination Treatment Modalities141
Saniona AB Pipeline Products Glance154
  Saniona AB Clinical Stage Pipeline Products151
    Phase II Products/Combination Treatment Modalities151
    Phase I Products/Combination Treatment Modalities161
  Saniona AB Early Stage Pipeline Products171
    Preclinical Products/Combination Treatment Modalities171
    Discovery Products/Combination Treatment Modalities181
Saniona AB Drug Profiles1925
  (metoprolol + tesofensine)191
    Product Description191
    Mechanism of Action191
    R&D Progress192
  NS-2359211
    Product Description211
    Mechanism of Action211
    R&D Progress212
  tesofensine231
    Product Description231
    Mechanism of Action231
    R&D Progress233
  AN-721261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  AN-788271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  AN-346281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  AN-470291
    Product Description291
    Mechanism of Action291
    R&D Progress292
  AN-761311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  NS-9283321
    Product Description321
    Mechanism of Action321
    R&D Progress322
  Small Molecule to Agonize GABAA Alpha 2 and Alpha 3 for Neuropathic Pain341
    Product Description341
    Mechanism of Action341
    R&D Progress341
  Small Molecules to Agonize nAChR Alpha7 for Pain and Alzheimer's Disease351
    Product Description351
    Mechanism of Action351
    R&D Progress351
  Small Molecule to Activate Kv7.2 and Kv7.3 Channels for Epilepsy and Pain361
    Product Description361
    Mechanism of Action361
    R&D Progress361
  Small Molecule to Activate TREK for Pain371
    Product Description371
    Mechanism of Action371
    R&D Progress371
  Small Molecule to Agonize GABA Alpha 4 Delta Receptor for Sleep Disorders, Stress and Autism381
    Product Description381
    Mechanism of Action381
    R&D Progress381
  Small Molecule to Agonize GABAA Receptor Subunit Alpha-4 and Gamma for Epilepsy391
    Product Description391
    Mechanism of Action391
    R&D Progress391
  Small Molecule to Agonize GABAA Receptor Subunit Alpha-5 for Autism401
    Product Description401
    Mechanism of Action401
    R&D Progress401
  Small Molecule to Agonize nAChR Alpha6 for Parkinson's Disease411
    Product Description411
    Mechanism of Action411
    R&D Progress411
  Small Molecule to Block TREK for Depression421
    Product Description421
    Mechanism of Action421
    R&D Progress421
  Small Molecule to Inhibit Monoamine Reuptake for Pain431
    Product Description431
    Mechanism of Action431
    R&D Progress431
Saniona AB Pipeline Analysis446
  Saniona AB Pipeline Products by Target442
  Saniona AB Pipeline Products by Route of Administration461
  Saniona AB Pipeline Products by Molecule Type471
  Saniona AB Pipeline Products by Mechanism of Action482
Saniona AB Recent Pipeline Updates501
Saniona AB Dormant Projects511
Saniona AB Discontinued Pipeline Products521
  Discontinued Pipeline Product Profiles521
    NS-2359521
    tesofensine521
Saniona AB Locations And Subsidiaries531
  Head Office531
Appendix542
  Methodology541
  Coverage541
  Secondary Research541
  Primary Research541
  Expert Panel Validation541
  Contact Us541
  Disclaimer551

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Saniona AB - Product Pipeline Review - 2016" Aug 17, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Saniona-AB-Product-Pipeline-Review-2016-2088-16407>
  
APA:
Global Markets Direct - Market Research. (2016). Saniona AB - Product Pipeline Review - 2016 Aug 17, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Saniona-AB-Product-Pipeline-Review-2016-2088-16407>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.